{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:39:27Z","timestamp":1792525167039,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T00:00:00Z","timestamp":1674000000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["australiancriticalcare.com","clinicalkey.com","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Australian Critical Care"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.aucc.2022.12.011","type":"journal-article","created":{"date-parts":[[2023,2,19]],"date-time":"2023-02-19T22:44:05Z","timestamp":1676846645000},"page":"933-939","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Benefits of pharmacist intervention in the critical care patients with infectious diseases: A propensity score matching retrospective cohort study"],"prefix":"10.1016","volume":"36","author":[{"given":"Hongyan","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuyun","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suozhu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3013-2832","authenticated-orcid":false,"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.aucc.2022.12.011_bib1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/cc1022","article-title":"Optimizing antibiotic therapy in the intensive care unit setting","volume":"5","author":"Kollef","year":"2001","journal-title":"Crit Care"},{"issue":"6","key":"10.1016\/j.aucc.2022.12.011_bib2","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1177\/1060028018825483","article-title":"Medication histories in critically ill patients completed by pharmacy personnel","volume":"53","author":"Kram","year":"2019","journal-title":"Ann Pharmacother"},{"issue":"1","key":"10.1016\/j.aucc.2022.12.011_bib3","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/cc9366","article-title":"Minimising drug errors in critically ill patients","volume":"15","author":"Carson-Stevens","year":"2011","journal-title":"Crit Care"},{"issue":"3","key":"10.1016\/j.aucc.2022.12.011_bib4","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/cc12698","article-title":"Antibiotics for the critically ill: more than just selecting appropriate initial therapy","volume":"17","author":"Kollef","year":"2013","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.aucc.2022.12.011_bib5","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s13054-019-2438-1","article-title":"Clinically relevant pharmacokinetic knowledge on antibiotic dosing among intensive care professionals is insufficient: a cross-sectional study","volume":"23","author":"Fleuren","year":"2019","journal-title":"Crit Care"},{"issue":"12","key":"10.1016\/j.aucc.2022.12.011_bib6","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1177\/1060028019864669","article-title":"The role of the clinical pharmacist in a preventive cardiology practice","volume":"53","author":"Warden","year":"2019","journal-title":"Ann Pharmacother"},{"issue":"1","key":"10.1016\/j.aucc.2022.12.011_bib7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1331\/JAPhA.2012.12501","article-title":"DOTx. MED: pharmacist-delivered interventions to improve care for patients with diabetes","volume":"52","author":"American Pharmacists","year":"2012","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"5","key":"10.1016\/j.aucc.2022.12.011_bib8","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1007\/s11096-018-0691-z","article-title":"Pharmacist's interventions improve time in therapeutic range of elderly rural patients on warfarin therapy: a randomized trial","volume":"40","author":"Falamic","year":"2018","journal-title":"Int J Clin Pharm"},{"issue":"6","key":"10.1016\/j.aucc.2022.12.011_bib9","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1097\/00003246-199406000-00027","article-title":"Impact of a clinical pharmacist in a multidisciplinary intensive care unit","volume":"22","author":"Montazeri","year":"1994","journal-title":"Crit Care Med"},{"issue":"9","key":"10.1016\/j.aucc.2022.12.011_bib10","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1097\/CCM.0000000000003830","article-title":"Impact on patient outcomes of pharmacist participation in multidisciplinary critical care teams: a systematic review and meta-analysis","volume":"47","author":"Lee","year":"2019","journal-title":"Crit Care Med"},{"issue":"4","key":"10.1016\/j.aucc.2022.12.011_bib11","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01825-17","article-title":"A\u00a0before-and-after study of the effectiveness of an antimicrobial stewardship program in critical care","volume":"62","author":"Alvarez-Lerma","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.aucc.2022.12.011_bib12","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1093\/cid\/ciw118","article-title":"Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America","volume":"62","author":"Barlam","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.aucc.2022.12.011_bib13","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1177\/1060028018759343","article-title":"Critical care pharmacists and medication management in an ICU recovery center","volume":"52","author":"Stollings","year":"2018","journal-title":"Ann Pharmacother"},{"issue":"12","key":"10.1016\/j.aucc.2022.12.011_bib14","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1097\/CCM.0b013e31818f2269","article-title":"Clinical and economic outcomes of involving pharmacists in the direct care of critically ill patients with infections","volume":"36","author":"MacLaren","year":"2008","journal-title":"Crit Care Med"},{"issue":"12","key":"10.1016\/j.aucc.2022.12.011_bib15","first-page":"3008","article-title":"Effect of pharmacist interventions on drug therapy costs in a surgical intensive-care unit","volume":"43","author":"Miyagawa","year":"1986","journal-title":"Am J Hosp Pharm"},{"issue":"3","key":"10.1016\/j.aucc.2022.12.011_bib16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1001\/jama.282.3.267","article-title":"Pharmacist participation on physician rounds and adverse drug events in the intensive care unit","volume":"282","author":"Leape","year":"1999","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.aucc.2022.12.011_bib17","first-page":"79","article-title":"Retrospect and prospect of the development of clinical pharmacy in China","volume":"31","author":"Cai Li-jian","year":"2010","journal-title":"Med Philos (Chinese)"},{"key":"10.1016\/j.aucc.2022.12.011_bib18","series-title":"Guidelines for ATC classification and DDD assignment","year":"2021"},{"key":"10.1016\/j.aucc.2022.12.011_bib19","series-title":"ATC\/DDD Index","year":"2021"},{"key":"10.1016\/j.aucc.2022.12.011_bib20","series-title":"Surveillance of Antimicrobial Use","year":"2021"},{"issue":"3","key":"10.1016\/j.aucc.2022.12.011_bib21","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3947\/ic.2021.0093","article-title":"Core elements for successful implementation of antimicrobial stewardship programs","volume":"53","author":"Hwang","year":"2021","journal-title":"Infect Chemother"},{"issue":"Suppl 1","key":"10.1016\/j.aucc.2022.12.011_bib22","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.cmi.2016.01.001","article-title":"Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005-2014","volume":"22","author":"Hu","year":"2016","journal-title":"Clin Microbiol Infect"},{"issue":"4 Suppl","key":"10.1016\/j.aucc.2022.12.011_bib23","doi-asserted-by":"crossref","first-page":"N108","DOI":"10.1097\/00003246-200104001-00010","article-title":"Intensive care unit antimicrobial resistance and the role of the pharmacist","volume":"29","author":"Ibrahim","year":"2001","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1016\/j.aucc.2022.12.011_bib24","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1093\/jac\/dkx435","article-title":"Pharmacist participation in antimicrobial stewardship in Australian and French hospitals: a cross-sectional nationwide survey","volume":"73","author":"Weier","year":"2018","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.aucc.2022.12.011_bib25","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.mcna.2018.05.009","article-title":"Role of the pharmacist in antimicrobial stewardship","volume":"102","author":"Diane","year":"2018","journal-title":"Med Clin North Am"},{"issue":"6","key":"10.1016\/j.aucc.2022.12.011_bib26","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ajic.2011.07.011","article-title":"Prospective audit for antimicrobial stewardship in intensive care: impact on resistance and clinical outcomes","volume":"40","author":"DiazGranados","year":"2012","journal-title":"Am J Infect Control"},{"issue":"3","key":"10.1016\/j.aucc.2022.12.011_bib27","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3346\/jkms.2014.29.3.431","article-title":"Current status of intensive care units registered as critical care subspecialty training hospitals in Korea","volume":"29","author":"Kwak","year":"2014","journal-title":"J\u00a0Korean Med Sci"},{"issue":"7","key":"10.1016\/j.aucc.2022.12.011_bib28","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1592\/phco.29.7.761","article-title":"Effects of pharmacist participation in intensive care units on clinical and economic outcomes of critically ill patients with thromboembolic or infarction-related events","volume":"29","author":"MacLaren","year":"2009","journal-title":"Pharmacotherapy"},{"issue":"2","key":"10.1016\/j.aucc.2022.12.011_bib29","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/CCM.0000000000002827","article-title":"Impact of quality bundle enforcement by a critical care pharmacist on patient outcome and costs","volume":"46","author":"Leguelinel-Blache","year":"2018","journal-title":"Crit Care Med"}],"container-title":["Australian Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1036731422002570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1036731422002570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T18:35:10Z","timestamp":1760898910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1036731422002570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S1036731422002570"],"URL":"https:\/\/doi.org\/10.1016\/j.aucc.2022.12.011","relation":{},"ISSN":["1036-7314"],"issn-type":[{"value":"1036-7314","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Benefits of pharmacist intervention in the critical care patients with infectious diseases: A propensity score matching retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Australian Critical Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aucc.2022.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Australian College of Critical Care Nurses Ltd. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}